Institut Curie
banner
institutcurie.bsky.social
Institut Curie
@institutcurie.bsky.social
🌐 Internationally renowned #Research Center
🏥 State-of-the-art Hospital Group
🇨🇵 France's leading #cancer center
curie.fr
👏 Félicitations au Dr Enzo Poirier, chargé de recherche @inserm.fr et chef d'équipe à l’Institut Curie qui a reçu le prix de la Fondation Joannidès de l'@academiesciences.bsky.social, saluant ses travaux de recherche sur l'immunité innée.
November 26, 2025 at 4:21 PM
👏 Félicitations au Dr Gudrun Schleiermacher, pédiatre oncologue à l’Institut Curie distinguée par l'@academiesciences.bsky.social par la médaille de Biologie humaine et sciences médicales pour ses travaux sur les mécanismes moléculaires des cancers pédiatriques et leur résistance aux traitements.
November 26, 2025 at 4:21 PM
Entre cartographie d'une terre inconnue et édition génétique, Têtes Chercheuse part aujourd'hui à la rencontre d'Antonin Morillon(@institutcurie.bsky.social/@cnrs.fr) qui nous dévoile ses travaux sur le "dark génome" et leur application face aux cancers.

▶️ curie.fr/actualite/po...
November 25, 2025 at 10:53 AM
A study recently published in The Lancet Regional Health – Europe shows the impact of the French national multidisciplinary tumour board coordinated by @institutcurie.bsky.social with a demonstrated survival benefit for patients with cancer of unknown primary: www.thelancet.com/journals/lan...
November 13, 2025 at 3:02 PM
📣 Discovery of a cellular resistance mechanism at the origin of relapses of triple-negative breast cancer: an essential step on the path towards more preventive medicine that is able to anticipate and avoid relapses.

▶️ institut-curie.org/news/relapse...
November 12, 2025 at 11:00 AM
🎙️ Dans le bureau-jardin du Dr Manuel Rodrigues, littérature, botanique et science se rencontrent pour raconter une même histoire : celle des signatures de l’ADN, ces empreintes qui révèlent l’origine de certaines tumeurs.

Nouvel épisode de Têtes Chercheuses, à écouter sur : curie.fr/actualite/po...
November 12, 2025 at 9:49 AM
🔈New crop of #ERC Synergy Grants for Institut Curie!
3 projects involving our researchers are on the list of winners of ERC Synergy Grants 2025: Nicolas Manel, Daniele Fachinetti, Stéphanie Descroix, Alexandre Baffet, Benoît Sorre, Leonid Mirny
➡️Learn more: institut-curie.org/news/new-cro...
#ERCSyG
November 10, 2025 at 4:43 PM
👏 Double success for @institutcurie.bsky.social & @minesparis-psl.bsky.social at MIDOG 2025: Prof. @thomas-walter.bsky.social team ranks 1st in mitosis classification and 2nd in detection, standing out among the leading groups in artificial intelligence applied to medical image analysis.
October 30, 2025 at 3:07 PM
🎧 Nouvelle saison de Têtes Chercheuses !

Sarah Watson, oncologue et chercheuse à l’Institut Curie, est spécialiste des cancers rares. Au micro de Zoé Varier, elle raconte la complexité de ces maladies et la dimension humaine qui la guide.

🎙️ À écouter dès maintenant : curie.fr/actualite/po...
October 28, 2025 at 10:22 AM
📣 Registration for the next international course at
@institutcurie.bsky.social on the innovative approaches for pediatric cancer immunotherapy is now open, until november 28th, 2025.

🗓️ January 28 - 30, 2026
▶️ More info: training.institut-curie.org/courses/inno...
October 23, 2025 at 10:19 AM
⏳ Last days to register to the Development & Cancer course at @institutcurie.bsky.social! Discover the current knowledge linking developmental biology with the cellular and molecular study of cancers with international experts.

Register now ▶️ training.institut-curie.org/courses/deve...
October 22, 2025 at 9:21 AM
🎙️ Le podcast de l'Institut Curie est de retour pour une deuxième saison ! RDV le 28 octobre pour 6 nouveaux épisodes qui vous feront plonger dans les laboratoires de l’Institut Curie et découvrir la science autrement. 👀
October 21, 2025 at 2:32 PM
Registration for the next international course at @institutcurie.bsky.social is open, until november 14th. This 2nd edition will focus on understanding the molecular basis of urothelial tumors to improve diagnosis and treatment.

📅 January 14-16, 2026
▶️ training.institut-curie.org/courses/urot...
October 21, 2025 at 10:09 AM
#ESMO25 | Studies of the French national coordination on unknown primary cancers (CUP) led by Institut Curie show the importance of a collaborative and multidisciplinary approach to improve targeted treatments in these rare cancers.

Learn more:
➡️ institut-curie.org/esmo2025

#OncSky #CUP
October 20, 2025 at 4:46 PM
#ESMO25 | New insights from the IMMUNOBIL phase II trial presented by Dr Matthieu Delaye (Institut Curie): a combination of 2 immunotherapies in advanced biliary tract cancer after platinum-based chemo shows promising survival for a subgroup of patients.

➡️ institut-curie.org/esmo2025
October 20, 2025 at 2:27 PM
#ESMO25 | Physicians and researchers from @institutcurie.bsky.social delighted to share their latest advances, innovations, and expertise to accelerate discoveries in #oncology for the benefit of patients 🤝

Learn more:
📍https://institut-curie.org/esmo2025
📍Booth Institut Curie / Hall 2.2b - #2036
October 20, 2025 at 9:59 AM
#ESMO25 | New insights from the SOHO-01 study presented by Prof. NIcolas Girard @institutcurie.bsky.social:
Molecular factors and ctDNA dynamics may help predict outcomes in patients with HER2-mutant #NSCLC treated with sevabertinib, paving the way for more personalized care.

#medonc #lungcancer
October 19, 2025 at 1:13 PM
#ESMO25 | Uveal melanoma: positive results of the phase 2 PLUME clinical trial, presented by Dr. Manuel Rodrigues @institutcurie.bsky.social (efficacy and tolerability of immunotherapy anti-PD-1 + targeted treatment)

➡️ Learn more:
institut-curie.org/news/metasta...
#medonc #oncalert
October 18, 2025 at 4:56 PM
#ESMO25 | Promising real-world data from the french multicenter LARENA study presented by Dr Diana Bello-Roufai @institutcurie.bsky.social, show that adapting pembrolizumab-lenvatinib dosing in metastatic endometrial cancer reduces toxicity without compromising efficacy.

#medonc
October 18, 2025 at 11:50 AM
#ESMO2025 | Finding Less Toxic Treatments for Women with Hormone-Dependent #BreastCancer.
Pr Paul Cottu (Institut Curie) presented preliminary results from the RIBOLARIS study, showing that in 52% of pts, chemotherapy could be replaced with a less toxic treatment
👉 institut-curie.org/news/less-to...
October 17, 2025 at 2:35 PM
📍 Expert scientists and clinicians of Institut Curie are attending #ESMO25, Europe’s key #oncology congress.
They’ll share promising results in breast cancer, uveal melanoma, cancers of unknown origin, and new therapeutic innovations for patients.
👉 institut-curie.org/esmo2025 @myesmo.bsky.social
October 17, 2025 at 2:22 PM
Registration is open for the next Genome Dynamics course at @institutcurie.bsky.social! This course will explore the full spectrum of genome biology bringing together international experts to share the latest experimental and computational advances ▶️ training.institut-curie.org/courses/Geno...
October 14, 2025 at 9:14 AM
A key mechanism behind Mycobacterium tuberculosis survival:
Researchers, including Dr. Ting-Di Wu from Institut Curie, found that the bacterium depends on a unique sulfate transporter — a potential target for new treatments without side effects on human cells.

🔗 www.pnas.org/doi/abs/10.1...
October 7, 2025 at 2:24 PM
🏛️ After the Panthéon, Marie Curie is now honored at the Musée Grévin in Paris! Institut Curie is proud to see #MarieCurie join the museum, celebrating her exceptional legacy that continues to inspire scientists worldwide.

📷 © Virginie Ribaut
October 2, 2025 at 1:30 PM
🔬For the 2025 Fête de la Science, Institut Curie opens its doors to the public! Follow the steps of Marie Curie’s research in Paris and explore the fascinating world of biology.

⏩https://www.fetedelascience.fr/la-fete-de-la-science-2025-l-institut-curie
October 1, 2025 at 1:38 PM